Nanogel-crosslinked nanoparticles increase the inhibitory effects of W9 synthetic peptide on bone loss in a murine bone resorption model

References

• AokiKAllesNSoysaNOhyaKPeptide-based delivery to boneAdv Drug Deliv Rev201264121220123822709649
   PubMedGoogle Scholar
• Kieber-EmmonsTMuraliRGreeneMITherapeutic peptides and peptidomimeticsCurr Opin Biotechnol1997844354419265722
   PubMedGoogle Scholar
• LowmanHBBacteriophage display and discovery of peptide leads for drug developmentAnnu Rev Biophys Biomol Struct1997264014249241425
   PubMedGoogle Scholar
• MalavoltaLPintoMRCuveroJHNakaieCRInterpretation of the dissolution of insoluble peptide sequences based on the acid-base properties of the solventProtein Sci20061561476148816731981
   PubMedGoogle Scholar
• ShiveMSAndersonJMBiodegradation and biocompatibility of PLA and PLGA microspheresAdv Drug Deliv Rev199728152410837562
   PubMed Web of Science ®Google Scholar
• HutchinsonFGFurrBJBiodegradable polymers for controlled release of peptides and proteinsHoriz Biochem Biophys198991111292656473
   PubMedGoogle Scholar
• LeeKYukSPolymeric protein delivery systemsProg Polym Sci2007327669697
   Web of Science ®Google Scholar
• MaoSSunWKisselTChitosan-based formulations for delivery of DNA and siRNAAdv Drug Deliv Rev2010621122719796660
   PubMed Web of Science ®Google Scholar
• KataokaKHaradaANagasakiYBlock copolymer micelles for drug delivery: design, characterization and biological significanceAdv Drug Deliv Rev200147111313111251249
   PubMed Web of Science ®Google Scholar
• NiuXFengQWangMGuoXZhengQPorous nano-HA/collagen/PLLA scaffold containing chitosan microspheres for controlled delivery of synthetic peptide derived from BMP-2J Control Release2009134211111719100794
   PubMed Web of Science ®Google Scholar
• AkiyoshiKDeguchiSMoriguchiNYamaguchiSSunamotoJSelf-aggregates of hydrophobized polysaccharides in water-formation and characeristics of nanoparticlesMacromolecules1993261230623068
   Web of Science ®Google Scholar
• AkiyoshiKKobayashiSShichibeSSelf-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: complexation and stabilization of insulinJ Control Release19985433133209766251
   PubMed Web of Science ®Google Scholar
• AkiyoshiKDeguchiSSunamotoJNishikawaTSunamotoJMicroscopic structure and thermoresponsiveness of a hydrogel nanoparticle by self-assembly of a hydrophobized polysaccharideMacromolecules1997304857861
   Web of Science ®Google Scholar
• MorimotoNEndoTIwasakiYAkiyoshiKDesign of hybrid hydrogels with self-assembled nanogels as cross-linkers: interaction with proteins and chaperone-like activityBiomacromolecules2005641829183416004415
   PubMed Web of Science ®Google Scholar
• UenakaAWadaHIsobeMT cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 proteinCancer Immun20077917441676
   PubMedGoogle Scholar
• KitanoSKageyamaSNagataYHER2-specific T-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulanClin Cancer Res200612247397740517189412
   PubMedGoogle Scholar
• ShimizuTKishidaTHasegawaUNanogel DDS enables sustained release of IL-12 for tumor immunotherapyBiochem Biophys Res Commun2008367233033518158918
   PubMed Web of Science ®Google Scholar
• ShimodaASawadaSKanoADual crosslinked hydrogel nanoparticles by nanogel bottom-up method for sustained-release deliveryColloids Surf B Biointerfaces201299384421996463
   PubMed Web of Science ®Google Scholar
• ChengJTeplyBASherifiIFormulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug deliveryBiomaterials200728586987617055572
   PubMed Web of Science ®Google Scholar
• LiYPeiYZhangXPEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in ratsJ Control Release200171220321111274752
   PubMed Web of Science ®Google Scholar
• EssaSRabanelJMHildgenPEffect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(D, L-lactide) (PLA) based nanoparticlesEur J Pharm Biopharm20107529610620211727
   PubMed Web of Science ®Google Scholar
• ZalipskySHarrisJIntroduction to chemistry and biological applications of poly(ethylene glycol)1997 Available from: http://pubs.acs.org/doi/pdf/10.1021/bk-1997-0680.ch001Accessed December 28, 2014
   Google Scholar
• HashimotoYMukaiSASawadaSSasakiYAkiyoshiKNanogel tectonic porous gel loading biologics, nanocarriers, and cells for advanced scaffoldBiomaterials20153710711525453324
   PubMed Web of Science ®Google Scholar
• WangRKreuzerHGrunzeMMolecular conformation and solvation of oligo(ethylene glycol)-terminated self-assembled monolayers and their resistance to protein adsorptionJ Phys Chem B19971014797679773
   Google Scholar
• ElbertDLHubbellJASelf-assembly and steric stabilization at heterogeneous, biological surfaces using adsorbing block copolymersChem Biol1998531771839545428
   PubMedGoogle Scholar
• AokiKSaitoHItzsteinCA TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone lossJ Clin Invest200611661525153416680194
   PubMedGoogle Scholar
• AokiKMaedaMNakaeTOkadaYOhyaKChibaKA disulfide bond replacement strategy enables the efficient design of artificial therapeutic peptidesTetrahedron2014704277747779
   Google Scholar
• SaitoHKojimaTTakahashiMA tumor necrosis factor receptor loop peptide mimic inhibits bone destruction to the same extent as anti-tumor necrosis factor monoclonal antibody in murine collagen-induced arthritisArthritis Rheum20075641164117417393436
   PubMed Web of Science ®Google Scholar
• AllesNSoysaNSHussainMDPolysaccharide nanogel delivery of a TNF-α and RANKL antagonist peptide allows systemic prevention of bone lossEur J Pharm Sci2009372838819429414
   PubMedGoogle Scholar
• SatoKSuematsuANakashimaTRegulation of osteoclast differentiation and function by the CaMK-CREB pathwayNat Med200612121410141617128269
   PubMed Web of Science ®Google Scholar
• KojimaTAokiKNonakaKSubcutaneous injections of a TNF-alpha antagonistic peptide inhibit both inflammation and bone resorption in collagen-induced murine arthritisJ Med Dent Sci2005521919915868746
   PubMedGoogle Scholar
• SuzukiYAokiKSaitoHA tumor necrosis factor-alpha antagonist inhibits inflammatory bone resorption induced by Porphyromonas gingivalis infection in miceJ Periodontal Res2006412819116499710
   PubMedGoogle Scholar
• SetoHAokiKKasugaiSOhyaKTrabecular bone turnover, bone marrow cell development, and gene expression of bone matrix proteins after low calcium feeding in ratsBone199925668769510593414
   PubMedGoogle Scholar
• BeamerWGShultzKLDonahueLRQuantitative trait loci for femoral and lumbar vertebral bone mineral density in C57BL/6J and C3H/HeJ inbred strains of miceJ Bone Miner Res20011671195120611450694
   PubMedGoogle Scholar
• NakachiHAokiKTomomatsuNA structural modulator of tumor necrosis factor type 1 receptor promotes bone formation under lipopolysaccharide-induced inflammation in a murine tooth extraction modelEur J Pharmacol20126791–313213822290392
   PubMedGoogle Scholar
• AllesNSoysaNSHayashiJSuppression of NF-kappaB increases bone formation and ameliorates osteopenia in ovariectomized miceEndocrinology2010151104626463420810563
   PubMedGoogle Scholar
• NagahamaKAokiKNonakaKThe deficiency of immunoregulatory receptor PD-1 causes mild osteopetrosisBone20043551059106815542030
   PubMedGoogle Scholar
• ParfittAMDreznerMKGlorieuxFHBone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature CommitteeJ Bone Miner Res1987265956103455637
   PubMed Web of Science ®Google Scholar
• DempsterDWCompstonJEDreznerMKStandardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature CommitteeJ Bone Miner Res201328121723197339
   PubMed Web of Science ®Google Scholar
• LaceyDLTimmsETanHLOsteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activationCell19989321651769568710
   PubMed Web of Science ®Google Scholar
• YasudaHShimaNNakagawaNIdentity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitroEndocrinology19981393132913379492069
   PubMed Web of Science ®Google Scholar